Carlos Panizo Santos-rekin lankidetzan egindako argitalpenak (2)

2017

  1. First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study

    European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43

2000

  1. First report of visceral leishmaniasis in an orthotopic heart transplant recipient [3]

    Transplantation